Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

11 Aug 2014

Black and Hispanic SLE patients are more likely to be readmitted than white patients

A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged.

11 Aug 2014

New handbook explains how to establish framework for experimental project

The effective design and analysis of experiments in biology are critical to success, yet graduate students in biological and medical sciences typically receive very little formal training in these steps.

8 Aug 2014

New questions arise about hospice companies as rates of discharge increase

When so many patients leave a hospice alive, it could signal problems such as inadequate care or companies seeking financial gains by enrolling people who should not have been considered hospice patients, The Washington Post reports.

7 Aug 2014

First MinuteClinic walk-in medical clinics in Nebraska

The first MinuteClinic walk-in medical clinics in Nebraska are opening this week inside select CVS/pharmacy stores. Two clinics opened yesterday in Lincoln and one is opening today in Omaha. A third clinic in Lincoln and three more clinics in the Omaha area will open later this month.

7 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

Pay-for-performance schemes only reduce patient death rates in the short term, finds new research

Pay-for-performance schemes - which reward hospitals financially for improving the quality of care provided to patients - only reduce patient death rates in the short term, according to new research by The University of Manchester.

From The University of Manchester 7 Aug 2014

First Edition: August 7, 2014

Today's headlines include stories about how uninsured people fare with the health law's exemptions.

7 Aug 2014

Eating pistachios may reduce body's response to stresses among adults with diabetes

Among people with type 2 diabetes, eating pistachios may reduce the body's response to the stresses of everyday life, according to Penn State researchers.

6 Aug 2014

Cancer fighter may also help patients survive pneumonia

The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report.

5 Aug 2014

Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.

5 Aug 2014

Research shows how bacteria in airways can help each other replenish vital iron

The body's assailants are cleverer than previously thought. New research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron.

5 Aug 2014

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

5 Aug 2014

NSAID use may mask early pneumonia symptoms

People with pneumococcal pneumonia who are taking nonsteroidal anti-inflammatory drugs at the point of diagnosis tend to develop more severe disease despite being younger and healthier than those not using these drugs, shows research.

4 Aug 2014

Preoperative urodynamics ‘has no added value’ in SUI patients

Preoperative urodynamic studies may be unnecessary in many women undergoing primary surgery for stress urinary incontinence, say the authors of a systematic review and meta-analysis.

4 Aug 2014

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).

4 Aug 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Black and Hispanic SLE patients are more likely to be readmitted than white patients

New handbook explains how to establish framework for experimental project

New questions arise about hospice companies as rates of discharge increase

First MinuteClinic walk-in medical clinics in Nebraska

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Pay-for-performance schemes only reduce patient death rates in the short term, finds new research

First Edition: August 7, 2014

Eating pistachios may reduce body's response to stresses among adults with diabetes

Cancer fighter may also help patients survive pneumonia

Laboratories at TSRI investigate antibodies to fight Ebola virus

Research shows how bacteria in airways can help each other replenish vital iron

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

NSAID use may mask early pneumonia symptoms

Preoperative urodynamics ‘has no added value’ in SUI patients

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Henry Schein net sales increase 9.3% to $2.6 billion in Q2 2014

Artesunate drug can be used to control asthma, finds NUS study

Common herbal-based anti-malarial drug can be used to control asthma, shows study

Biologists identify signaling pathway that switches on calorie-burning process in brown fat cells

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in